Loading clinical trials...
Loading clinical trials...
At-Home Transcranial Direct Current Stimulation (tDCS) Using the NettleEndo Device for Reducing Symptoms of Endometriosis - A Pivotal Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Conditions
Interventions
NettleEndo
Sham NettleEndo Device
Locations
1
United States
Alethios, Inc.
San Francisco, California, United States
Start Date
December 4, 2025
Primary Completion Date
July 1, 2026
Completion Date
August 1, 2026
Last Updated
December 18, 2025
NCT07472842
NCT07471373
NCT05951452
NCT06611501
NCT07100782
NCT05726786
Lead Sponsor
Samphire Group, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions